CeraPedics Inc., a Lakewood, Colo.-based developer of products for the orthopedic bone substitutes market, has secured $14.45 million of a $16.45 million Series A round, according to a regulatory filing. OrbiMed Advisors led the deal, with Medical Capital Advisors serving as a placement agent. www.cerapedics.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.